However, clinical data shows that about 70% of patients report significant improvement or resolution of nausea by week 8 to 12 of consistent treatment
These findings provided a novel perspective for further research and interventions for these diseases
Early evaluation cannot reverse existing damage, but it can rule out other treatable causes and help protect the remaining vision in both eyes
They can appear similar from a patient perspective, but doctors choose between them based on medical history, goals, and tolerance
In contrast, the role of humoral immunity remains unclear
Supply Planning Each vial provides 25 doses regardless of reconstitution choice (2.5 mL 0.1 mL = 5 mL 0.2 mL = 25): Weeks 1-4 (daily): 28 doses Weeks 5-8 (5x weekly): 20 doses Weeks 9-12 (2-3x weekly): 8-12 doses Total: 56-60 doses, usually 3 vials for a 12-week protocol Supporting Factors: Diet, Vitamins, Hydration, Sleep Optional adjuncts: Red light therapy (630-670 nm): 10-20 min daily Microneedling: Every 3-4 weeks during Phase 2 When Progress Stalls during a GLOW / KLOW Protocol Each stall pattern has a different fix, and the signal is what distinguishes them not the impulse to push harder